McDaniel Terry & Co’s AbbVie ABBV Stock Holding History

McDaniel Terry & Co’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.62M	Buy	12,059 +1,009	+9%	+$224K	0.22%	37
2025 Q4	$2.52M	Sell	11,050 -3,192	-22%	-$727K	0.22%	35
2025 Q3	$3.3M	Sell	14,242 -40	-0.3%	-$8.15K	0.27%	35
2025 Q2	$2.65M	Sell	14,282 -89	-0.6%	-$16.5K	0.22%	37
2025 Q1	$3.01M	Sell	14,371 -134	-0.9%	-$26.1K	0.26%	36
2024 Q4	$2.58M	Sell	14,505 -2	-0%	-$368	0.21%	38
2024 Q3	$2.87M	Sell	14,507 -63	-0.4%	-$11.8K	0.24%	37
2024 Q2	$2.5M	Sell	14,570 -335	-2%	-$55.5K	0.22%	38
2024 Q1	$2.71M	Sell	14,905 -2,707	-15%	-$467K	0.24%	37
2023 Q4	$2.73M	Sell	17,612 -371	-2%	-$54.1K	0.26%	36
2023 Q3	$2.68M	Buy	17,983 +3,197	+22%	+$469K	0.28%	37
2023 Q2	$1.99M	Buy	14,786 +494	+3%	+$72.4K	0.2%	38
2023 Q1	$2.28M	Buy	14,292 +49	+0.3%	+$7.49K	0.25%	35
2022 Q4	$2.3M	Sell	14,243 -630	-4%	-$96.6K	0.27%	36
2022 Q3	$2M	Sell	14,873 -55	-0.4%	-$7.89K	0.26%	36
2022 Q2	$2.29M	Sell	14,928 -2,082	-12%	-$318K	0.28%	35
2022 Q1	$2.76M	Buy	17,010 +1,822	+12%	+$265K	0.3%	35
2021 Q4	$2.06M	Buy	15,188 +49	+0.3%	+$5.79K	0.21%	39
2021 Q3	$1.63M	Buy	15,139 +61	+0.4%	+$6.97K	0.19%	36
2021 Q2	$1.7M	Sell	15,078 -26	-0.2%	-$2.93K	0.2%	35
2021 Q1	$1.64M	Buy	15,104 +59	+0.4%	+$6.31K	0.2%	35
2020 Q4	$1.61M	Buy	15,045 +24	+0.2%	+$2.31K	0.2%	33
2020 Q3	$1.32M	Buy	15,021 +25	+0.2%	+$2.35K	0.19%	36
2020 Q2	$1.47M	Buy	14,996 +357	+2%	+$31.4K	0.22%	35
2020 Q1	$1.11M	Sell	14,639 -705	-5%	-$60K	0.21%	32
2019 Q4	$1.36M	Sell	15,344 -176	-1%	-$14.6K	0.2%	34
2019 Q3	$1.18M	Buy	15,520 +492	+3%	+$33.7K	0.19%	35
2019 Q2	$1.09M	Sell	15,028 -4,667	-24%	-$367K	0.18%	35
2019 Q1	$1.59M	Buy	19,695 +752	+4%	+$61.5K	0.27%	30
2018 Q4	$1.75M	Buy	18,943 +10	+0.1%	+$879	0.34%	30
2018 Q3	$1.79M	Buy	18,933 +368	+2%	+$34.9K	0.3%	30
2018 Q2	$1.72M	Buy	18,565 +17	+0.1%	+$1.66K	0.32%	30
2018 Q1	$1.76M	Buy	18,548 +11	+0.1%	+$1.21K	0.32%	29
2017 Q4	$1.79M	Sell	18,537 -113	-0.6%	-$10.7K	0.32%	29
2017 Q3	$1.66M	Buy	18,650 +16	+0.1%	+$1.22K	0.31%	29
2017 Q2	$1.35M	Sell	18,634 -238	-1%	-$16K	0.26%	30
2017 Q1	$1.23M	Sell	18,872 -481	-2%	-$30.2K	0.24%	30
2016 Q4	$1.21M	Buy	19,353 +516	+3%	+$31.5K	0.25%	31
2016 Q3	$1.19M	Sell	18,837 -1,077	-5%	-$69.7K	0.25%	30
2016 Q2	$1.23M	Buy	19,914 +5,668	+40%	+$345K	0.28%	28
2016 Q1	$814K	Buy	14,246 +18	+0.1%	+$1K	0.19%	29
2015 Q4	$843K	Buy	14,228 +14	+0.1%	+$806	0.22%	29
2015 Q3	$773K	Buy	14,214 +1,684	+13%	+$110K	0.22%	28
2015 Q2	$842K	Buy	12,530 +500	+4%	+$32.6K	0.21%	31
2015 Q1	$704K	Hold	12,030	–	–	0.17%	31
2014 Q4	$787K	Hold	12,030	–	–	0.19%	31
2014 Q3	$695K	Sell	12,030 -200	-2%	-$11.1K	0.17%	33
2014 Q2	$690K	Hold	12,230	–	–	0.16%	34
2014 Q1	$629K	Hold	12,230	–	–	0.16%	36
2013 Q4	$646K	Hold	12,230	–	–	0.16%	37
2013 Q3	$547K	Sell	12,230 -150	-1%	-$6.65K	0.15%	39
2013 Q2	$512K	Buy	+12,380	New	+$541K	0.15%	40

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

McDaniel Terry & Co's ABBV Position: Q1 2026 in Review

McDaniel Terry & Co increased its AbbVie (ABBV) stake by 9.1% in Q1 2026, buying an estimated $224K and bringing the position to 12,059 shares worth $2.62M. The position accounts for 0.22% of the portfolio, ranked #37.

McDaniel Terry & Co first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.3M in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

McDaniel Terry & Co held 12,059 shares of AbbVie worth $2.62M as of Q1 2026.
McDaniel Terry & Co bought 1,009 AbbVie shares in Q1 2026, an estimated $224K.
AbbVie made up 0.22% of McDaniel Terry & Co's portfolio in Q1 2026, its #37 holding.
McDaniel Terry & Co first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
McDaniel Terry & Co's AbbVie position peaked at $3.3M in Q3 2025.
4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on McDaniel Terry & Co's 13F filing for Q1 2026, filed 5 May 2026.